109 related articles for article (PubMed ID: 10772108)
1. Acute, subchronic, and chronic toxicity of ecadotril in dogs.
Maertins T; von Keutz E; Goetze L
Am J Vet Res; 2000 Apr; 61(4):425-9. PubMed ID: 10772108
[TBL] [Abstract][Full Text] [Related]
2. Short-term effects of ecadotril in dogs with induced congestive heart failure.
Olivier NB; Kutas SM; Beals S; Hanson B; Windram S
Am J Vet Res; 2000 Mar; 61(3):333-8. PubMed ID: 10714529
[TBL] [Abstract][Full Text] [Related]
3. Intrarenal effects of ecadotril during acute volume expansion in dogs with congestive heart failure.
Solter P; Sisson D; Thomas W; Goetze L
J Pharmacol Exp Ther; 2000 Jun; 293(3):989-95. PubMed ID: 10869402
[TBL] [Abstract][Full Text] [Related]
4. Lack of efficacy of neutral endopeptidase inhibitor ecadotril in heart failure. The International Ecadotril Multi-centre Dose-ranging Study Investigators.
Cleland JG; Swedberg K
Lancet; 1998 May; 351(9116):1657-8. PubMed ID: 9620738
[No Abstract] [Full Text] [Related]
5. A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: the U.S. ecadotril pilot safety study.
O'Connor CM; Gattis WA; Gheorghiade M; Granger CB; Gilbert J; McKenney JM; Messineo FC; Burnett JC; Katz SD; Elkayam U; Kasper EK; Goldstein S; Cody RJ; Massie BM
Am Heart J; 1999 Dec; 138(6 Pt 1):1140-8. PubMed ID: 10577446
[TBL] [Abstract][Full Text] [Related]
6. Effects of chronic neutral endopeptidase inhibition on the progression of left ventricular dysfunction and remodeling in dogs with moderate heart failure.
Mishima T; Tanimura M; Suzuki G; Todor A; Sharov VG; Tanhehco EJ; Goldstein S; Sabbah HN
Cardiovasc Drugs Ther; 2002 May; 16(3):209-14. PubMed ID: 12374898
[TBL] [Abstract][Full Text] [Related]
7. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
Wegner M; Hirth-Dietrich C; Stasch JP
Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
[TBL] [Abstract][Full Text] [Related]
8. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic neutral endopeptidase inhibition in rats with cyclosporine-induced hypertension.
Takeda Y; Inaba S; Furukawa K; Fujimura A; Miyamori I; Mabuchi H
J Hypertens; 2000 Jul; 18(7):927-33. PubMed ID: 10930191
[TBL] [Abstract][Full Text] [Related]
10. Renal and antihypertensive effects of neutral endopeptidase inhibition in transgenic rats with an extra renin gene.
Stasch JP; Hirth-Dietrich C; Ganten D; Wegner M
Am J Hypertens; 1996 Aug; 9(8):795-802. PubMed ID: 8862226
[TBL] [Abstract][Full Text] [Related]
11. Ecadotril. (S)-acetorphan, sinorphan.
Drugs R D; 1999 Apr; 1(4):343-5. PubMed ID: 10566059
[No Abstract] [Full Text] [Related]
12. Effect of ecadotril, a neutral endopeptidase inhibitor, on myocardial hypertrophy in the rat aortic insufficiency model.
Kimura M; Umemura K; Ohashi K; Nakashima M
Can J Cardiol; 1998 Jan; 14(1):63-8. PubMed ID: 9487275
[TBL] [Abstract][Full Text] [Related]
13. Clinical potential of endopeptidase-24.11 inhibitors in cardiovascular disease.
Wilkins MR
Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):673-8. PubMed ID: 8224488
[No Abstract] [Full Text] [Related]
14. Introduction. Enkephalinase inhibition: a rational approach to antisecretory therapy for acute diarrhoea.
Farthing MJ
Aliment Pharmacol Ther; 1999 Dec; 13 Suppl 6():1-2. PubMed ID: 10646044
[No Abstract] [Full Text] [Related]
15. Racecadotril versus placebo in the treatment of acute diarrhoea in adults.
Hamza H; Ben Khalifa H; Baumer P; Berard H; Lecomte JM
Aliment Pharmacol Ther; 1999 Dec; 13 Suppl 6():15-9. PubMed ID: 10646047
[TBL] [Abstract][Full Text] [Related]
16. Strategies for access to enantiomerically pure ecadotril, dexecadotril and fasidotril: a review.
Monteil T; Danvy D; Sihel M; Leroux R; Plaquevent JC
Mini Rev Med Chem; 2002 Jun; 2(3):209-17. PubMed ID: 12370063
[TBL] [Abstract][Full Text] [Related]
17. Effect of sinorphan on plasma atrial natriuretic factor in congestive heart failure.
Kahn JC; Patey M; Dubois-Rande JL; Merlet P; Castaigne A; Lim-Alexandre C; Lecomte JM; Duboc D; Gros C; Schwartz JC
Lancet; 1990 Jan; 335(8681):118-9. PubMed ID: 1967410
[No Abstract] [Full Text] [Related]
18. Comparison of racecadotril and loperamide in adults with acute diarrhoea.
Vetel JM; Berard H; Fretault N; Lecomte JM
Aliment Pharmacol Ther; 1999 Dec; 13 Suppl 6():21-6. PubMed ID: 10646048
[TBL] [Abstract][Full Text] [Related]
19. Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition.
Cruden NL; Fox KA; Ludlam CA; Johnston NR; Newby DE
Hypertension; 2004 Dec; 44(6):913-8. PubMed ID: 15492133
[TBL] [Abstract][Full Text] [Related]
20. [Action of acetorphan, an enkephalinase inhibitor, in acute diarrhea].
Baumer P; Danquechin Dorval E; Bertrand J; Vetel JM; Schwartz JC; Lecomte JM
Ann Gastroenterol Hepatol (Paris); 1992; 28(6-7):279-85. PubMed ID: 1285638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
